Cocrystal Pharma, Inc.
COCP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001412486
In the last 90 days, Cocrystal Pharma, Inc. insiders filed 2 open-market purchases and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.17M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Cocrystal Pharma, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 33 | 27 | −6 |
| Shares | 14.2M | 13.6M | −658.5K (−4.6%) |
| Value | $5.83M | $3.95M | −$1.88M (−32.3%) |
New holders (3)
Institutions that held Cocrystal Pharma, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 79,918 | $23.0K | 0.00% |
| Virtu Financial LLC | 48,017 | $14.0K | 0.00% |
| Millennium Management LLC | 10,555 | $3.00K | 0.00% |
Sold out (9)
Institutions that held Cocrystal Pharma, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Brighton Jones LLC | 28,000 | $11.0K |
| Western Wealth Management, LLC | 22,815 | $10.0K |
| Jane Street Group, LLC | 14,845 | $6.00K |
| Goldman Sachs Group Inc | 12,747 | $5.00K |
| Victory Capital Management Inc | 12,598 | $5.00K |
| HRT Financial LP | 12,508 | $5.00K |
| Captrust Financial Advisors | 2,303 | $1.00K |
| Huntington National Bank | 833 | $0 |
| Joseph P. Lucia & Associates, LLC | 200 | $0 |